IRAN Is About To Make The Stock Market Go Insane
7 extracted signals · 7 resolved · 0 still active
StockedUpIndependent analyst profile- Source published
- 07 Jul 2026, 22:04 UTC
- Recorded by Tahlil Plus
- 15 Jul 2026, 14:57 UTC
AI-generated source summary
The analysis covers several key stocks, highlighting their recent price action and potential future movements. TSLA showed a bearish reversal after breaking below a support level, with a potential target of $390 and a failure bound at $413.51. XLE, XOM, CVX, and OXY exhibited bullish price action, driven by strong sector performance, with targets set at their recent highs or slightly above. XLE targets $55.50 with failure at $53.40, XOM targets $145.00 with failure at $140.85, CVX targets $176.54 with failure at $171.12, and OXY targets $52.50 with failure at $50.20. DKNG showed a strong upward trend after a significant prior drop, with potential upside to $29.70 and failure at $25.95. INTC, however, experienced a sharp decline, with a target of $108.05 and failure at $113.51, indicating a bearish outlook.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
7 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
StockedUp
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.